Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vigantol in Chronic Heart Failure
NCT01535196Phase 3Terminated
- Sponsor
- Semmelweis University
- Start
- Dec 2012
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of cholecalciferol in chronic heart failure (CHF), sponsored by Semmelweis University. Started Dec 2012; status: terminated.
02
Drugs
cholecalciferol
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT01535196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01535196.